drugset / Trial / NCT02266537

Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male Volunteers

NCT02266537

Phase 1 Completed 97 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The study was aimed to evaluate the pharmacological effect of different α-antagonists on phenylephrine induced pupil size in healthy male volunteers as pharmacological basis for Intraoperative floppy iris syndrome (IFIS)

Timeline

Start
2005-11
Primary completion
2006-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfuzosin Small molecule
Subject Doxazosin Small molecule
Subject Tamsulosin Other / unclassified

Indications

No indication recorded.